Chiltern Acquires Singapore-based Pacific Clinical Research

September 29, 2014

Applied Clinical Trials

Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore.

Chiltern has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens in particular Chiltern's oncology and anti-infective offerings. Its executive management join the Chiltern management team.

Read the full release here.

Related Content:

News